Raju S Kucherlapati - Net Worth and Insider Trading
Raju S Kucherlapati Net Worth
The estimated net worth of Raju S Kucherlapati is at least $293,530 dollars as of 2024-09-21. Raju S Kucherlapati is the Director of AVEO Pharmaceuticals Inc and owns about 19,542 shares of AVEO Pharmaceuticals Inc (AVEO) stock worth over $293,130. Raju S Kucherlapati is also the Director of Gelesis Holdings Inc and owns about 190,264 shares of Gelesis Holdings Inc (GLSHQ) stock worth over $400. Details can be seen in Raju S Kucherlapati's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Raju S Kucherlapati has not made any transactions after 2022-11-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Raju S Kucherlapati
Raju S Kucherlapati Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Raju S Kucherlapati owns 2 companies in total, including AVEO Pharmaceuticals Inc (AVEO) , and Gelesis Holdings Inc (GLSHQ) .
Click here to see the complete history of Raju S Kucherlapati’s form 4 insider trades.
Insider Ownership Summary of Raju S Kucherlapati
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AVEO | AVEO Pharmaceuticals Inc | 2012-12-13 | director |
GLSHQ | Gelesis Holdings Inc | 2022-11-21 | director |
Raju S Kucherlapati Latest Holdings Summary
Raju S Kucherlapati currently owns a total of 2 stocks. Among these stocks, Raju S Kucherlapati owns 19,542 shares of AVEO Pharmaceuticals Inc (AVEO) as of December 13, 2012, with a value of $293,130 and a weighting of 99.86%. Raju S Kucherlapati also owns 190,264 shares of Gelesis Holdings Inc (GLSHQ) as of November 21, 2022, with a value of $400 and a weighting of 0.14%.
Latest Holdings of Raju S Kucherlapati
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AVEO | AVEO Pharmaceuticals Inc | 2012-12-13 | 19,542 | 15.00 | 293,130 |
GLSHQ | Gelesis Holdings Inc | 2022-11-21 | 190,264 | 0.00 | 400 |
Holding Weightings of Raju S Kucherlapati
Raju S Kucherlapati Form 4 Trading Tracker
According to the SEC Form 4 filings, Raju S Kucherlapati has made a total of 0 transactions in AVEO Pharmaceuticals Inc (AVEO) over the past 5 years. The most-recent trade in AVEO Pharmaceuticals Inc is the acquisition of 1,500 shares on December 13, 2012, which cost Raju S Kucherlapati around $101,100.
According to the SEC Form 4 filings, Raju S Kucherlapati has made a total of 1 transactions in Gelesis Holdings Inc (GLSHQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Gelesis Holdings Inc is the acquisition of 100,000 shares on November 21, 2022, which cost Raju S Kucherlapati around $45,000.
Insider Trading History of Raju S Kucherlapati
- 1
Raju S Kucherlapati Trading Performance
GuruFocus tracks the stock performance after each of Raju S Kucherlapati's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Raju S Kucherlapati is -0.87%. GuruFocus also compares Raju S Kucherlapati's trading performance to market benchmark return within the same time period. The performance of stocks bought by Raju S Kucherlapati within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Raju S Kucherlapati's insider trading performs compared to the benchmark.
Performance of Raju S Kucherlapati
Raju S Kucherlapati Ownership Network
Raju S Kucherlapati Owned Company Details
What does AVEO Pharmaceuticals Inc do?
Who are the key executives at AVEO Pharmaceuticals Inc?
Raju S Kucherlapati is the director of AVEO Pharmaceuticals Inc. Other key executives at AVEO Pharmaceuticals Inc include Chief Operating Officer Jebediah Ledell , director & President & CEO Michael P Bailey , and Chief Commercial Officer Michael Ferraresso .
AVEO Pharmaceuticals Inc (AVEO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc (AVEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc (AVEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AVEO Pharmaceuticals Inc (AVEO)'s detailed insider trading history can be found in Insider Trading Tracker table.
AVEO Pharmaceuticals Inc Insider Transactions
Raju S Kucherlapati Mailing Address
Above is the net worth, insider trading, and ownership report for Raju S Kucherlapati. You might contact Raju S Kucherlapati via mailing address: 77 Louis Pasteur Avenue, Boston Ma 02115.